Expression profiles of MUC mucins and trefoil factor family (TFF) peptides in the intrahepatic biliary system: Physiological distribution and pathological significance

Progress in Histochemistry and Cytochemistry

Volumn 42, Issue 2, 2007, Pages 61-110

  Sasaki, Motoko ^a   Ikeda, Hiroko ^a   Nakanuma, Yasuni ^a  

^a KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

Author keywords

Biliary epithelial cells; Biliary epithelial dysplasia; Cholangiocarcinoma; Hepatolithiasis; Intrahepatic biliary system; MUC mucin core protein; Trefoil factor family (TFF)

Indexed keywords

BIOLOGICAL MARKER; GENE PRODUCT; MESSENGER RNA; MUCIN; MUCIN 1; MUCIN 11; MUCIN 12; MUCIN 13; MUCIN 15; MUCIN 16; MUCIN 17; MUCIN 2; MUCIN 3; MUCIN 4; MUCIN 5AC; MUCIN 5B; MUCIN 6; MUCIN 7; MUCIN 8; PEPTIDE; TREFOIL FACTOR FAMILY PEPTIDE; UNCLASSIFIED DRUG;

ANATOMY; ARTICLE; BILE DUCT; BILE DUCT CARCINOMA; BILE DUCT STONE; BILE SECRETION; CARCINOMA CELL; DYSPLASIA; EMBRYOLOGY; EPITHELIUM CELL; GALLBLADDER CARCINOMA; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC CODE; GENETIC IDENTIFICATION; HEPATOBILIARY DISEASE; HEPATOBILIARY SYSTEM; HISTOCHEMISTRY; HUMAN; INFLAMMATORY DISEASE; INTRAHEPATIC BILE DUCT; NONHUMAN; PATHOLOGY; PHYSIOLOGY; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; REGULATORY MECHANISM; UPREGULATION;

LOTUS;

EID: 34347204093     PISSN: 00796336     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.proghi.2007.02.001     Document Type: Article

References (227)

1. Adsay N.V., Merati K., Basturk O., Iacobuzio-Donahue C., Levi E., Cheng J.D., et al. Pathologically and biologically distinct types of epithelium in intraductal papillary mucinous neoplasms: delineation of an "intestinal" pathway of carcinogenesis in the pancreas. Am J Surg Pathol 28 7 (2004) 839-848
2. Aishima S., Kuroda Y., Nishihara Y., Taguchi K., Taketomi A., Maehara Y., et al. Gastric mucin phenotype defines tumour progression and prognosis of intrahepatic cholangiocarcinoma: gastric foveolar type is associated with aggressive tumour behaviour. Histopathology 49 1 (2006) 35-44
3. Aknin M.L., Berry M., Dick A.D., and Khan-Lim D. Normal but not altered mucins activate neutrophils. Cell Tissue Res 318 3 (2004) 545-551
4. Amaya S., Sasaki M., Watanabe Y., Tsui W.M., Tsuneyama K., Harada K., et al. Expression of MUC1 and MUC2 and carbohydrate antigen Tn change during malignant transformation of biliary papillomatosis. Histopathology 38 6 (2001) 550-560
5. Bartman A.E., Buisine M.P., Aubert J.P., Niehans G.A., Toribara N.W., Kim Y.S., et al. The MUC6 secretory mucin gene is expressed in a wide variety of epithelial tissues. J Pathol 186 4 (1998) 398-405
6. Basbaum C., Lemjabbar H., Longphre M., Li D., Gensch E., and McNamara N. Control of mucin transcription by diverse injury-induced signaling pathways. Am J Respir Crit Care Med 160 5 Pt 2 (1999) S44-S48
7. Baus-Loncar M., and Giraud A.S. Multiple regulatory pathways for trefoil factor (TFF) genes. Cell Mol Life Sci 62 24 (2005) 2921-2931
8. Beck S., Schmitt H., Shizuya H., Blin N., and Gott P. Cloning of continuous genomic fragments from human chromosome 21 harboring three trefoil peptide genes. Hum Genet 98 (1996) 233-235
9. Bloom W. The embryogenesis of human bile capillaries and ducts. Am J Anat 36 (1925-26) 451-466
10. Bobek L.A., Tsai H., Biesbrock A.R., and Levine M.J. Molecular cloning, sequence, and specificity of expression of the gene encoding the low molecular weight human salivary mucin (MUC7). J Biol Chem 268 27 (1993) 20563-20569
11. Bobek L.A., Liu J., Sait S.N., Shows T.B., Bobek Y.A., and Levine M.J. Structure and chromosomal localization of the human salivary mucin gene, MUC7. Genomics 31 3 (1996) 277-282
12. Bresalier R.S., Niv Y., Byrd J.C., Duh Q.Y., Toribara N.W., Rockwell R.W., et al. Mucin production by human colonic carcinoma cells correlates with their metastatic potential in animal models of colon cancer metastasis. J Clin Invest 87 3 (1991) 1037-1045
13. Brodt P., Fallavollita L., Bresalier R.S., Meterissian S., Norton C.R., and Wolitzky B.A. Liver endothelial E-selectin mediates carcinoma cell adhesion and promotes liver metastasis. Int J Cancer 71 4 (1997) 612-619
14. Buisine M.P., Devisme L., Degand P., Dieu M.C., Gosselin B., Copin M.C., et al. Developmental mucin gene expression in the gastroduodenal tract and accessory digestive glands. II. Duodenum and liver, gallbladder, and pancreas. J Histochem Cytochem 48 12 (2000) 1667-1676
15. Burchell J., Gendler S., Taylor-Papadimitriou J., Girling A., Lewis A., Millis R., et al. Development and characterization of breast cancer reactive monoclonal antibodies directed to the core protein of the human milk mucin. Cancer Res 47 20 (1987) 5476-5482
16. Burt A.D., Stewart J.A., Aitchison M., and MacSween R.N. Expression of tissue polypeptide antigen (TPA) in fetal and adult liver: changes in liver disease. J Clin Pathol 40 7 (1987) 719-724
17. Byrd J.C., and Bresalier R.S. Mucins and mucin binding proteins in colorectal cancer. Cancer Metastasis Rev 23 1-2 (2004) 77-99
18. Carone F., Bacallao R., and Kanwar Y. Biology of polycystic kidney disease. Lab Invest 70 (1994) 437-448
19. Chen T., Nakanuma Y., Zen Y., Chen M., Jan Y., Yeh T., et al. Intraductal papillary neoplasmof the liver associated with hepatolithiasis. Hepatology 34 (2001) 651-658
20. Chinery R., Williamson J., and Poulsom R. The gene encoding human intestinal trefoil factor (TFF3) is located on chromosome 21q22.3 clustered with other members of the trefoil peptide family. Genomics 32 2 (1996) 281-284
21. Choudhury A., Moniaux N., Winpenny J.P., Hollingsworth M.A., Aubert J.P., and Batra S.K. Human MUC4 mucin cDNA and its variants in pancreatic carcinoma. J Biochem (Tokyo) 128 2 (2000) 233-243
22. Colombari R., and Tsui W.M. Biliary tumors of the liver. Semin Liver Dis 15 4 (1995) 402-413
23. Cone R., and Schlaepfer E. Improved in situ hybridization of HIV with RNA probes derived from PCR products. J Histochem Cytochem 45 (1997) 721-727
24. Crawley S.C., Gum Jr. J.R., Hicks J.W., Pratt W.S., Aubert J.P., Swallow D.M., et al. Genomic organization and structure of the 3′ region of human MUC3: alternative splicing predicts membrane-bound and soluble forms of the mucin. Biochem Biophys Res Commun 263 3 (1999) 728-736
25. Desmet V.J. Congenital diseases of intrahepatic bile ducts: variations on the theme "ductal plate malformation". Hepatology 16 4 (1992) 1069-1083
26. Desseyn J.L., Aubert J.P., Van Seuningen I., Porchet N., and Laine A. Genomic organization of the 3′ region of the human mucin gene MUC5B. J Biol Chem 272 27 (1997) 16873-16883
27. Desseyn J.L., Guyonnet-Duperat V., Porchet N., Aubert J.P., and Laine A. Human mucin gene MUC5B, the 10.7-kb large central exon encodes various alternate subdomains resulting in a super-repeat. Structural evidence for a 11p15.5 gene family. J Biol Chem 272 6 (1997) 3168-3178
28. Desseyn J.L., Buisine M.P., Porchet N., Aubert J.P., Degand P., and Laine A. Evolutionary history of the 11p15 human mucin gene family. J Mol Evol 46 1 (1998) 102-106
29. Desseyn J.L., Aubert J.P., Porchet N., and Laine A. Evolution of the large secreted gel-forming mucins. Mol Biol Evol 17 8 (2000) 1175-1184
30. Dignass A., Lynch-Denaney K., Kindin H., Thim L., and Podolsky D. trefoil peptides promote epithelial migration through a transforming growth factor beta-independent pathway. J Clin Invest 94 (1994) 376-383
31. Ee H.C., Erler T., Bhathal P.S., Young G.P., and James R.J. Cdx-2 homeodomain protein expression in human and rat colorectal adenoma and carcinoma. Am J Pathol 147 3 (1995) 586-592
32. Ellingham R., Berry M., Stevenson D., and Corfield A. Secreted human conjunctival mucus contains MUC5AC glycoforms. Glycobiology 9 (1999) 1181-1189
33. Finzi L., Barbu V., Burgel P.R., Mergey M., Kirkwood K.S., Wick E.C., et al. MUC5AC, a gel-forming mucin accumulating in gallstone disease, is overproduced via an epidermal growth factor receptor pathway in the human gallbladder. Am J Pathol 169 6 (2006) 2031-2041
34. Fussey S., Guest J., James O., Bassendine M., and Yeaman S. Identification and analysis of the major M2 autoantigens in primary biliary cirrhosis. Proc Natl Acad Sci USA 85 22 (1988) 8654-8658
35. Gabow P. Autosomal dominant polycystic kidney disease. N Engl J Med 329 (1993) 332
36. Gabow P., Johnson A., kaehney W., Manco-Johnson M., Duley I., and Everson G. Risk factors of the development of hepatic cysts in autosomal dominant polycystic kidney disease. Hepatology 11 (1990) 1033-1037
37. Gall J.A., and Bhathal P.S. Morphological and immunohistochemical assessment of intrahepatic bile duct development in the rat. J Gastroenterol Hepatol 4 3 (1989) 241-250
38. Gendler S.J., Spicer A.P., Lalani E.N., Duhig T., Peat N., Burchell J., et al. Structure and biology of a carcinoma-associated mucin, MUC1. Am Rev Respir Dis 144 3, Part 2 (1991) S42-S47
39. Gershwin M.E., Mackay I.R., Sturgess A., and Coppel R.L. Identification and specificity of a cDNA encoding the 70 kd mitochondrial antigen recognized in primary biliary cirrhosis. J Immunol 138 10 (1987) 3525-3531
40. Ghosh M., Kamma H., Kawamoto T., Koike N., Miwa M., Kapoor V.K., et al. MUC 1 core protein as a marker of gallbladder malignancy. Eur J Surg Oncol 31 8 (2005) 891-896
41. Gores G.J. Cholangiocarcinoma: current concepts and insights. Hepatology 37 5 (2003) 961-969
42. Goto M., Shibahara H., Tamada S., Hamada T., Oda K., Nagino M., et al. Aberrant expression of pyloric gland-type mucin in mucin-producing bile duct carcinomas: a clear difference between the core peptide and the carbohydrate moiety. Pathol Int 55 8 (2005) 464-470
43. Gott P., Beck S., Machado J., Camiero F., Schmitt H., and Blin N. Human trefoil peptides: Genomic structure in 21q22.3 and coordinated expression. Eur J Hum Genet 4 (1996) 308-315
44. Griffiths B., Matthews D.J., West L., Attwood J., Povey S., Swallow D.M., et al. Assignment of the polymorphic intestinal mucin gene (MUC2) to chromosome 11p15. Ann Hum Genet 54 Part 4 (1990) 277-285
45. Gum J.R., Byrd J.C., Hicks J.W., Toribara N.W., Lamport D.T., and Kim Y.S. Molecular cloning of human intestinal mucin cDNAs. Sequence analysis and evidence for genetic polymorphism. J Biol Chem 264 11 (1989) 6480-6487
46. Gum J.R., Hicks J.W., Swallow D.M., Lagace R.L., Byrd J.C., Lamport D.T., et al. Molecular cloning of cDNAs derived from a novel human intestinal mucin gene. Biochem Biophys Res Commun 171 1 (1990) 407-415
47. Gum Jr. J.R., Hicks J.W., Gillespie A.M., Carlson E.J., Komuves L., Karnik S., et al. Goblet cell-specific expression mediated by the MUC2 mucin gene promoter in the intestine of transgenic mice. Am J Physiol 276 3, Part 1 (1999) G666-G676
48. Gum Jr. J.R., Crawley S.C., Hicks J.W., Szymkowski D.E., and Kim Y.S. MUC17, a novel membrane-tethered mucin. Biochem Biophys Res Commun 291 3 (2002) 466-475
49. Gupta S., Seith A., and Dhiman R. CT of liver cysts in patients with autosomal dominant polycystic kidney disease. Acta Radiol 40 (1999) 444-448
50. Gurbuz Y., and Kloppel G. Differentiation pathways in duodenal and ampullary carcinomas: a comparative study on mucin and trefoil peptide expression, including gastric and colon carcinomas. Virchows Arch 444 6 (2004) 536-541
51. Guyonnet Duperat V., Audie J.P., Debailleul V., Laine A., Buisine M.P., Galiegue-Zouitina S., et al. Characterization of the human mucin gene MUC5AC: a consensus cysteine-rich domain for 11p15 mucin genes?. Biochem J 305 Part 1 (1995) 211-219
52. Hartman M., Baruch A., Ron I., Aderet Y., Yoeli M., Sagi-Assif O., et al. MUC1 isoform specific monoclonal antibody 6E6/2 detects preferential expression of the novel MUC1/Y protein in breast and ovarian cancer. Int J Cancer 82 2 (1999) 256-267
53. Hauser F., Poulsom R., Chinery R., Rogers L., Hanby A., Wright N., et al. hP1.B, a human P domain peptide homologous with rat intestinal trefoil factor, is expressed also in the ulcer-associated cell lineage and the uterus. Proc Natl Acad Sci USA 90 6961-6965 (1993)
54. Higashi M., Yonezawa S., Ho J.J., Tanaka S., Irimura T., Kim Y.S., et al. Expression of MUC1 and MUC2 mucin antigens in intrahepatic bile duct tumors: its relationship with a new morphological classification of cholangiocarcinoma. Hepatology 30 6 (1999) 1347-1355
55. Hinoi T., Loda M., and Fearon E.R. Silencing of CDX2 expression in colon cancer via a dominant repression pathway. J Biol Chem 278 45 (2003) 44608-44616
56. Ho S.B., Dvorak L.A., Moor R.E., Jacobson A.C., Frey M.R., Corredor J., et al. Cysteine-rich domains of muc3 intestinal mucin promote cell migration, inhibit apoptosis, and accelerate wound healing. Gastroenterology 131 5 (2006) 1501-1517
57. Hoffmann W. Trefoil factors TFF (trefoil factor family) peptide-triggered signals promoting mucosal restitution. Cell Mol Life Sci 62 24 (2005) 2932-2938
58. Hoffmann W., and Joba W. Biosynthesis and molecular architecture of gel-forming mucins: implications from an amphibian model system. Biochem Soc Trans 23 4 (1995) 805-810
59. Hoffmann W., Jagla W., and Wiede A. Molecular medicine of TFF-peptides: from gut to brain. Histol Histopathol 16 1 (2001) 319-334
60. Hori Y., Spurr-Michaud S., Russo C.L., Argueso P., and Gipson I.K. Differential regulation of membrane-associated mucins in the human ocular surface epithelium. Invest Ophthalmol Vis Sci 45 1 (2004) 114-122
61. Horinouchi M., Nagata K., Nakamura A., Goto M., Takao S., Sakamoto M., et al. Expression of different glycoforms of membrane mucin (MUC1) and secretory mucin (MUC2, MUC5AC and MUC6) in pancreatic neoplasms. Acta Histochem Cytochem 36 (2003) 443-453
62. Hruban R.H., Adsay N.V., Albores-Saavedra J., Compton C., Garrett E.S., Goodman S.N., et al. Pancreatic intraepithelial neoplasia: a new nomenclature and classification system for pancreatic duct lesions. Am J Surg Pathol 25 5 (2001) 579-586
63. Huang L., Chen D., Liu D., Yin L., Kharbanda S., and Kufe D. MUC1 oncoprotein blocks glycogen synthase kinase 3beta-mediated phosphorylation and degradation of beta-catenin. Cancer Res 65 22 (2005) 10413-10422
64. Idilman R., Erden E., Arat M., Soydan E., Erkan O., Kuzu I., et al. Trefoil factor expression in biliary epithelium of graft-versus-host disease of the liver after allogeneic hematopoietic cell transplantation. Transplantation 80 8 (2005) 1099-1104
65. Ikeda H, Sasaki M, Ishikawa A, Sato Y, Harada K, Kazumori H, Nakanuma Y. Interaction of Toll-like receptors with bacterial components induces expression of CDX2 and MUC2 in rat biliary epithelium in vivo and in cell culture. Lab Invest 2007; in press.
66. Ikeda K., Saitoh S., Koida I., Arase Y., Tsubota A., Chayama K., et al. A multivariate analysis of risk factors for hepatocellular carcinogenesis: a prospective observation of 795 patients with viral and alcoholic cirrhosis. Hepatology 18 1 (1993) 47-53
67. Irimura T., Denda K., Iida S., Takeuchi H., and Kato K. Diverse glycosylation of MUC1 and MUC2: potential significance in tumor immunity. J Biochem (Tokyo) 126 6 (1999) 975-985
68. Ishikawa A., Sasaki M., Ohira S., Ohta T., Oda K., Nimura Y., et al. Aberrant expression of CDX2 is closely related to the intestinal metaplasia and MUC2 expression in intraductal papillary neoplasm of the liver in hepatolithiasis. Lab Invest 84 5 (2004) 629-638
69. Japan L.C.S.G.O. Classification of primary liver cancer (1997), Kanehara-Shuppan, Tokyo
70. Jerome K.R., Barnd D.L., Bendt K.M., Boyer C.M., Taylor-Papadimitriou J., McKenzie I.F., et al. Cytotoxic T-lymphocytes derived from patients with breast adenocarcinoma recognize an epitope present on the protein core of a mucin molecule preferentially expressed by malignant cells. Cancer Res 51 11 (1991) 2908-2916
71. Jumblatt J.E., Cunningham L.T., Li Y., and Jumblatt M.M. Characterization of human ocular mucin secretion mediated by 15(S)-HETE. Cornea 21 8 (2002) 818-824
72. Jung H.H., Lee J.H., Kim Y.T., Lee S.D., and Park J.H. Expression of mucin genes in chronic ethmoiditis. Am J Rhinol 14 3 (2000) 163-170
73. Kaji K., Nakanuma Y., Sasaki M., Unoura M., Kobayashi K., Nonomura A., et al. Hepatitic bile duct injuries in chronic hepatitis C: histopathologic and immunohistochemical studies. Mod Pathol 7 9 (1994) 937-945
74. Kamihira T., Shimoda S., Harada K., Kawano A., Handa M., Baba E., et al. Distinct costimulation dependent and independent autoreactive T-cell clones in primary biliary cirrhosis. Gastroenterology 125 5 (2003) 1379-1387
75. Kaplan M. Primary biliary cirrhosis. N Engl J Med 335 21 (1996) 1570-1580
76. Keates A.C., Nunes D.P., Afdhal N.H., Troxler R.F., and Offner G.D. Molecular cloning of a major human gall bladder mucin: complete C-terminal sequence and genomic organization of MUC5B. Biochem J 324 Part 1 (1997) 295-303
77. Khayyata S., Basturk O., and Adsay N.V. Invasive micropapillary carcinomas of the ampullo-pancreatobiliary region and their association with tumor-infiltrating neutrophils. Mod Pathol 18 11 (2005) 1504-1511
78. Kida T., Nakanuma Y., and Terada T. Cystic dilatation of peribiliary glands in livers with adult polycystic disease and livers with solitary nonpaprsitic cysts: an autopsy study. Hepatology 16 (1992) 334-340
79. Kim Y.S., and Gum Jr. J.R. Diversity of mucin genes, structure, function, and expression. Gastroenterology 109 3 (1995) 999-1001
80. Kim K.C., Wasano K., Niles R.M., Schuster J.E., Stone P.J., and Brody J.S. Human neutrophil elastase releases cell surface mucins from primary cultures of hamster tracheal epithelial cells. Proc Natl Acad Sci USA 84 24 (1987) 9304-9308
81. Kim G.E., Bae H.I., Park H.U., Kuan S.F., Crawley S.C., Ho J.J., et al. Aberrant expression of MUC5AC and MUC6 gastric mucins and sialyl Tn antigen in intraepithelial neoplasms of the pancreas. Gastroenterology 123 4 (2002) 1052-1060
82. Kim C.H., Kim H.J., Song K.S., Seong J.K., Kim K.S., Lee J.G., et al. MUC8 as a ciliated cell marker in human nasal epithelium. Acta Otolaryngol 125 1 (2005) 76-81
83. Kimura Y., Leung P.S., Kenny T.P., Van De Water J., Nishioka M., Giraud A.S., et al. Differential expression of intestinal trefoil factor in biliary epithelial cells of primary biliary cirrhosis. Hepatology 36 5 (2002) 1227-1235
84. Kinami Y., Noto K., Miyazaki I., and Matsubara F. A study of hepatolithiasis related to cholangiocarcinoma (in Japanese). Acta Hepatol Japan 19 (1978) 578-583
85. Kinoshita T., Taupin D., Itoh H., and Podolsky D. Distinct pathways of cell migration and antiapoptotic response to epithelial injury: structure-function analysis of human intestinal trefoil factor. Mol Cell Biol 20 (2000) 4680-4690
86. Kita H., Matsumura S., He X.S., Ansari A.A., Lian Z.X., Van de Water J., et al. Quantitative and functional analysis of PDC-E2-specific autoreactive cytotoxic T lymphocytes in primary biliary cirrhosis. J Clin Invest 109 9 (2002) 1231-1240
87. Kitamura H., Cho M., Lee B.H., Gum J.R., Siddiki B.B., Ho S.B., et al. Alteration in mucin gene expression and biological properties of HT29 colon cancer cell subpopulations. Eur J Cancer 32A 10 (1996) 1788-1796
88. Kobayashi M., Ikeda K., Saitoh S., Suzuki F., Tsubota A., Suzuki Y., et al. Incidence of primary cholangiocellular carcinoma of the liver in japanese patients with hepatitis C virus-related cirrhosis. Cancer 88 11 (2000) 2471-2477
89. Komatsu M., Jepson S., Arango M.E., Carothers Carraway C.A., and Carraway K.L. Muc4/sialomucin complex, an intramembrane modulator of ErbB2/HER2/Neu, potentiates primary tumor growth and suppresses apoptosis in a xenotransplanted tumor. Oncogene 20 4 (2001) 461-470
90. Kudo M. Hepatic peribiliary cysts: clinically harmless disease with potential risk due to gradual increase in size and number. J Gastroenterol 36 (2001) 286-288
91. Kufe D., Inghiram G., Abe M., Hayes D., Justi-heeler H., and Schlom J. Differential diagnosis of a novel monoclonal antibody (DF-3) with human malignant versus benign breast tumors. Hybridoma 3 (1984) 223-232
92. Kuper H., Ye W., Broome U., Romelsjo A., Mucci L.A., Ekbom A., et al. The risk of liver and bile duct cancer in patients with chronic viral hepatitis, alcoholism, or cirrhosis. Hepatology 34 4, Part 1 (2001) 714-718
93. Kurumaya H., Ohta G., and Nakanuma Y. Endocrine cells in the intrahepatic biliary tree in normal livers and hepatolithiasis. Arch Pathol Lab Med 113 2 (1989) 143-147
94. Kurumaya H., Terada T., and Nakanuma Y. 'Metaplastic lesions' in intrahepatic bile ducts in hepatolithiasis: a histochemical and immunohistochemical study. J Gastroenterol Hepatol 5 5 (1990) 530-536
95. Lalani E., Williams R., jayaram Y., Gilbert C., Chaudhary K., Siu L., et al. Trefoil Factor-2, human spasmolytic polypeptide, promotes branching morphogenesis in MCF-7 cells. Lab Invest 79 5 (1999) 537-5446
96. Lazaridis K.N., Strazzabosco M., and Larusso N.F. The cholangiopathies: disorders of biliary epithelia. Gastroenterology 127 5 (2004) 1565-1577
97. Lee K.T., and Liu T.S. Altered mucin gene expression in stone-containing intrahepatic bile ducts and cholangiocarcinomas. Dig Dis Sci 46 10 (2001) 2166-2172
98. Lefebvre O., Chenard M., Masson R., Linares J., Dierich A., Lemeur M., et al. Gastric mucosa abnormalities and tumorgenesis in mice lacking the pS2 trefoil protein. Science 274 (1996) 259-262
99. Leiper K., Campbell B.J., Jenkinson M.D., Milton J., Yu L.G., Democratis J., et al. Interaction between bacterial peptides, neutrophils and goblet cells: a possible mechanism for neutrophil recruitment and goblet cell depletion in colitis. Clin Sci (Lond) 101 4 (2001) 395-402
100. Li Y., Ren J., Yu W., Li Q., Kuwahara H., Yin L., et al. The epidermal growth factor receptor regulates interaction of the human DF3/MUC1 carcinoma antigen with c-Src and beta-catenin. J Biol Chem 276 38 (2001) 35239-35242
101. Longman R.J., Douthwaite J., Sylvester P.A., Poulsom R., Corfield A.P., Thomas M.G., et al. Coordinated localisation of mucins and trefoil peptides in the ulcer associated cell lineage and the gastrointestinal mucosa. Gut 47 6 (2000) 792-800
102. Lorentz O., Cadoret A., Duluc I., Capeau J., Gespach C., Cherqui G., et al. Downregulation of the colon tumour-suppressor homeobox gene Cdx-2 by oncogenic ras. Oncogene 18 1 (1999) 87-92
103. Luttges J., Feyerabend B., Buchelt T., Pacena M., and Kloppel G. The mucin profile of noninvasive and invasive mucinous cystic neoplasms of the pancreas. Am J Surg Pathol 26 4 (2002) 466-471
104. Mack D.R., Michail S., Wei S., McDougall L., and Hollingsworth M.A. Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression. Am J Physiol 276 4, Part 1 (1999) G941-G950
105. MacPherson B.R., and Pemsingh R.S. Ground squirrel model for cholelithiasis: role of epithelial glycoproteins. Microsc Res Tech 39 1 (1997) 39-55
106. MacSween R., Desmet V., Roskams T., and Scothorne R. Developmental anatomy and normal structure. In: MacSween R., Burt A., Portmann B., Ishak K., Scheuer P., and Anthony P. (Eds). Pathology of the liver (2002), Churchill-Livingstone, London 1-66
107. Mallo G.V., Soubeyran P., Lissitzky J.C., Andre F., Farnarier C., Marvaldi J., et al. Expression of the Cdx1 and Cdx2 homeotic genes leads to reduced malignancy in colon cancer-derived cells. J Biol Chem 273 22 (1998) 14030-14036
108. Mashimo H., Wu D., Podolsky D., and Fishman M. Impaired defense of intestinal mucosa in mice lacking intestinal trefoil factor. Science 274 (1996) 262-265
109. Mehrotra R., Thornton D.J., and Sheehan J.K. Isolation and physical characterization of the MUC7 (MG2) mucin from saliva: evidence for self-association. Biochem J 334 Part 2 (1998) 415-422
110. Mitoma J., Petryniak B., Hiraoka N., Yeh J.C., Lowe J.B., and Fukuda M. Extended core 1 and core 2 branched O-glycans differentially modulate sialyl Lewis X-type L-selectin ligand activity. J Biol Chem 278 11 (2003) 9953-9961
111. Mochizuki T., We G., Hayashi T., Xenophontos S., Veldhuisen B., Saris J., et al. PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein. Science 31, 272 5266 (1996) 1339-1342
112. Moll R., Franke W.W., Schiller D.L., Geiger B., and Krepler R. The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell 31 1 (1982) 11-24
113. Mollenhauer J., Wiemann S., Scheurlen W., Korn B., Hayashi Y., Wilgenbus K.K., et al. DMBT1, a new member of the SRCR superfamily, on chromosome 10q25.3-26.1 is deleted in malignant brain tumours. Nat Genet 17 1 (1997) 32-39
114. Mollenhauer J., Herbertz S., Helmke B., Kollender G., Krebs I., Madsen J., et al. Deleted in malignant brain tumors 1 Is a versatile mucin-like molecule likely to play a differential role in digestive tract cancer. Cancer Res 61 24 (2001) 8880-8886
115. Muenphon K., Limpaiboon T., Jearanaikoon P., Pairojkul C., Sripa B., and Bhudhisawasdi V. Amplification of chromosome 21q22.3 harboring trefoil factor family genes in liver fluke related cholangiocarcinoma is associated with poor prognosis. World J Gastroenterol 12 26 (2006) 4143-4148
116. Muskett F.W., May F.E., Westley B.R., and Feeney J. Solution structure of the disulfide-linked dimer of human intestinal trefoil factor (TFF3): the intermolecular orientation and interactions are markedly different from those of other dimeric trefoil proteins. Biochemistry 42 51 (2003) 15139-15147
117. Nakanuma Y., and Ohta G. Histometric and serial section observations of the intrahepatic bile ducts in primary biliary cirrhosis. Gastroenterology 76 6 (1979) 1326-1332
118. Nakanuma Y., and Sasaki M. Expression of blood-group-related antigens in the intrahepatic biliary tree and hepatocytes in normal livers and various hepatobiliary diseases. Hepatology 10 (1989) 174-178
119. Nakanuma Y., Terada T., Tanaka Y., and Ohta G. Are hepatolithiasis and cholangiocarcinoma aetiologically related? A morphological study of 12 cases of hepatolithiasis. Virchows Arch A 406 (1985) 45-58
120. Nakanuma Y., Yamaguchi K., Ohta G., and Terada T. Pathologic features of hepatolithiasis in Japan. Hum Pathol 19 (1988) 1181-1186
121. Nakanuma Y., Sasaki M., Terada T., and Harada K. Intrahepatic peribiliary glands of humans. II Pathological spectrum. J Gastroenterol Hepatol 9 (1994) 80-86
122. Nakanuma Y., Sripa B., and Vatanasapt V. Intrahepaic cholangiocarcinoma. In: Hamilton S., and Aaltonen L. (Eds). Pathology and genetics. Tumours of the digestive system (2000), IARC, Lyon 173-180
123. Nakayama F., Soloway R., and Nakama T. Hepatolithiasis in East Asia. Retrospective study. Dig Dis Sci 31 21-26 (1986)
124. Nguyen V.C., Aubert J.P., Gross M.S., Porchet N., Degand P., and Frezal J. Assignment of human tracheobronchial mucin gene(s) to 11p15 and a tracheobronchial mucin-related sequence to chromosome 13. Hum Genet 86 2 (1990) 167-172
125. Nozaki I., Lunz III J.G., Specht S., Park J.I., Giraud A.S., Murase N., et al. Regulation and function of trefoil factor family 3 expression in the biliary tree. Am J Pathol 165 6 (2004) 1907-1920
126. Osako M., Yonezawa S., Siddiki B., Huang J., Ho J.J., Kim Y.S., et al. Immunohistochemical study of mucin carbohydrates and core proteins in human pancreatic tumors. Cancer 71 7 (1993) 2191-2199
127. Park W.S., Oh R.R., Park J.Y., Lee J.H., Shin M.S., Kim H.S., et al. Somatic mutations of the trefoil factor family 1 gene in gastric cancer. Gastroenterology 119 3 (2000) 691-698
128. Patel T. Worldwide trends in mortality from biliary tract malignancies. BMC Cancer 2 (2002) 10
129. Paulsen F., and Berry M. Mucins and TFF peptides of the tear film and lacrimal appratus. Prog Histochem Cytochem 41 1 (2006) 1-53
130. Paulsen F., Langer G., Hoffmann W., and Berry M. Human lacrimal gland mucins. Cell Tissue Res 316 2 (2004) 167-177
131. Paulsen F.P., Varoga D., Paulsen A.R., Corfield A., and Tsokos M. Prognostic value of mucins in the classification of ampullary carcinomas. Hum Pathol 37 2 (2006) 160-167
132. Perez A., Barco R., Fernandez I., Price-Schiavi S.A., and Carraway K.L. PEA3 transactivates the Muc4/sialomucin complex promoter in mammary epithelial and tumor cells. J Biol Chem 278 38 (2003) 36942-36952
133. Pigny P., Guyonnet-Duperat V., Hill A.S., Pratt W.S., Galiegue-Zouitina S., d'Hooge M.C., et al. Human mucin genes assigned to 11p15.5: identification and organization of a cluster of genes. Genomics 38 3 (1996) 340-352
134. Pinto-de-Sousa J., David L., Reis C.A., Gomes R., Silva L., and Pimenta A. Mucins MUC1, MUC2, MUC5AC and MUC6 expression in the evaluation of differentiation and clinico-biological behaviour of gastric carcinoma. Virchows Arch 440 3 (2002) 304-310
135. Playford R., Marchbank T., Chinery R., Evison R., Pignatelli M., Boulton R., et al. Human spasmolytic polypeptide is a cytoprotective agent that stimulates cell migration. Gastroenterology 108 (1995) 108-116
136. Podolsky D. Mucosal Immunity and Inflammation V. Innate mechanisms of mucosal defense and repair: the best offence is a good defense. Am J Physiol 277 (1999) G495-G499
137. Portmann B., and Nakanuma Y. Diseases of the bile ducts. In: MacSween R., Burt A., BC P., Ishak K., Scheuer P., and Anthony P. (Eds). Pathology of the liver (2001), Churchill Livingstone, London 435-506
138. Portmann B., and Nakanuma Y. Diseases of the bile ducts. In: MacSween R., Burt A., Portmann B., Ishak K., Scheuer P., and Anthony P. (Eds). Pathology of the liver (2002), Churchill Livingstone, London 435-506
139. Poulsom R., Begos D., and Modlin I. Molecular aspects of restitution: functions of trefoil peptides. Yale J Biol Med 69 (1996) 137-146
140. Pratt W.S., Crawley S., Hicks J., Ho J., Nash M., Kim Y.S., et al. Multiple transcripts of MUC3: evidence for two genes, MUC3A and MUC3B. Biochem Biophys Res Commun 275 3 (2000) 916-923
141. Ramos A., Torres V., Holley K., Offord K., Rakela J., and Ludwig J. The liver in autosomal dominant polycystic kidney disease. Arch Pathol Lab Med 114 (1990) 180-184
142. Ramsauer V.P., Carraway C.A., Salas P.J., and Carraway K.L. Muc4/sialomucin complex, the intramembrane ErbB2 ligand, translocates ErbB2 to the apical surface in polarized epithelial cells. J Biol Chem 278 32 (2003) 30142-30147
143. Rousseau K., Byrne C., Kim Y.S., Gum J.R., Swallow D.M., and Toribara N.W. The complete genomic organization of the human MUC6 and MUC2 mucin genes. Genomics 83 5 (2004) 936-939
144. Ruchaud-Sparagano M.H., Westley B.R., and May F.E. The trefoil protein TFF1 is bound to MUC5AC in human gastric mucosa. Cell Mol Life Sci 61 15 (2004) 1946-1954
145. Sasaki M., and Nakanuma Y. Expression of mucin core protein of mammary type in primary liver cancer. Hepatology 20 5 (1994) 1192-1197
146. Sasaki M., and Nakanuma Y. Abnormal expression of MUC1 apomucin and mature MUC1 mucin in biliary epithelial cells in various cystic liver diseases. Hepatology 24 3 (1996) 539-543
147. Sasaki M., and Nakanuma Y. Frequent expression of MUC1 apomucin on biliary epithelial cells of damaged small bile ducts in primary biliary cirrhosis and chronic viral hepatitis: an immunohistochemical study. Hepatology 23 6 (1996) 1313-1317
148. Sasaki M., Kono N., and Nakanuma Y. Neoexpression of Lewis Y antigen is a sensitive phenotypic change of the damaged intrahepatic bile ducts. Hepatology 19 1 (1994) 138-144
149. Sasaki M., Nakanuma Y., Terada T., and Kim Y.S. Biliary epithelial expression of MUC1, MUC2, MUC3 and MUC5/6 apomucins during intrahepatic bile duct development and maturation. An immunohistochemical study. Am J Pathol 147 3 (1995) 574-579
150. Sasaki M., Nakanuma Y., and Kim Y. Characterization of apomicin expression in intrahepatic cholangio-carcinomas ans their precursor lesions: an immunohistochemical study. Hepatology 24 (1996) 1074-1078
151. Sasaki M., Nakanuma Y., Ho S.B., and Kim Y.S. Cholangiocarcinomas arising in cirrhosis and combined hepatocellular-cholangiocellular carcinomas share apomucin profiles. Am J Clin Pathol 109 3 (1998) 302-308
152. Sasaki M., Nakanuma Y., Ho S.B., and Kim Y.S. Increased MUC6 apomucin expression is a characteristic of reactive biliary epithelium in chronic viral hepatitis. J Pathol 185 2 (1998) 191-198
153. Sasaki M., Nakanuma Y., and Kim Y. Expression of apomucins in the intrahepatic biliary tree in hepatolithiasis differs from that in normal liver and extrahepatic biliary obstruction. Hepatology 27 (1998) 46-53
154. Sasaki M., Nakanuma Y., and Kim Y.S. Expression of apomucins in the intrahepatic biliary tree in hepatolithiasis differs from that in normal liver and extrahepatic biliary obstruction. Hepatology 27 1 (1998) 54-61
155. Sasaki M., Yamato T., Nakanuma Y., Ho S.B., and Kim Y.S. Expression of MUC2, MUC5AC and MUC6 apomucins in carcinoma, dysplasia and non-dysplastic epithelia of the gallbladder. Pathol Int 49 1 (1999) 38-44
156. Sasaki M., Ansari A.A., Nakanuma Y., Coppel R.L., Keeffe E.B., and Gershwin M.E. The immunopathology of primary biliary cirrhosis: thoughts for the millennium. Arch Immunol Ther Exp (Warsz) 48 1 (2000) 1-10
157. Sasaki M., Huang S.F., Chen M.F., Jan Y.Y., Yeh T.S., Ishikawa A., et al. Expression of deleted in malignant brain tumor-1 (DMBT1) molecule in biliary epithelium is augmented in hepatolithiasis: possible participation in lithogenesis. Dig Dis Sci 48 7 (2003) 1234-1240
158. Sasaki M., Tsuneyama K., Ishikawa A., and Nakanuma Y. Intrahepatic cholangiocarcinoma in cirrhosis presents granulocyte and granulocyte-macrophage colony-stimulating factor. Hum Pathol 34 12 (2003) 1337-1344
159. Sasaki M., Tsuneyama K., and Nakanuma Y. Aberrant expression of trefoil factor family-1 in biliary epithelium in hepatolithiasis and cholangiocarcinoma. Lab Invest 83 10 (2003) 1403-1413
160. Sasaki M., Ikeda H., Ohira S., Ishikawa A., and Nakanuma Y. Expression of trefoil factor family 1, 2, and 3 peptide is augmented in hepatolithiasis. Peptides 25 5 (2004) 763-770
161. Sasaki M., Tsuneyama K., Saito T., Kataoka H., Mollenhauer J., Poustka A., et al. Site-characteristic expression and induction of trefoil factor family 1, 2 and 3 and malignant brain tumor-1 in normal and diseased intrahepatic bile ducts relates to biliary pathophysiology. Liver Int 24 1 (2004) 29-37
162. Sasaki M., Ikeda H., Haga H., Manabe T., and Nakanuma Y. Frequent cellular senescence in small bile ducts in primary biliary cirrhosis: a possible role in bile duct loss. J Pathol 205 4 (2005) 451-459
163. Sasaki M., Ikeda H., and Nakanuma Y. Expression profiles of MUC mucin core proteins in the intrahepatic biliary system: physiological distribution and pathological significance. Acta Histochem Cytochem 38 5 (2005) 295-303
164. Sasaki M., Ikeda H., Kataoka H., and Nakanuma Y. Augmented expression of hepatocytes growth factor activator inhibitor type 1 (HAI-1) in intrahepatic small bile ducts in primary biliary cirrhosis. Virchows Arch 449 4 (2006) 462-471
165. Sasaki M., Ikeda H., Sato Y., and Nakanuma Y. Decreased expression of Bmi1 is closely associated with cellular senescence in small bile ducts in primary biliary cirrhosis. Am J Pathol 169 3 (2006) 831-845
166. Scheuer P. Liver biopsy interpretation, 5th ed (1994), Saunders, London
167. Seib T., Blin N., Hilgert K., Seifert M., Theisinger B., Engel M., et al. the three human trefoil genes TFF1, TFF2, and TFF3 are located within a region of 55 kb on chromosome 21q22.3. Genomics 40 (1997) 200-202
168. Shah K.D., and Gerber M.A. Development of intrahepatic bile ducts in humans. Immunohistochemical study using monoclonal cytokeratin antibodies. Arch Pathol Lab Med 113 10 (1989) 1135-1138
169. Shaib Y.H., Davila J.A., McGlynn K., and El-Serag H.B. Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase?. J Hepatol 40 3 (2004) 472-477
170. Shaib Y.H., El-Serag H.B., Davila J.A., Morgan R., and McGlynn K.A. Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study. Gastroenterology 128 3 (2005) 620-626
171. Shankar V., Pichan P., Eddy Jr. R.L., Tonk V., Nowak N., Sait S.N., et al. Chromosomal localization of a human mucin gene (MUC8) and cloning of the cDNA corresponding to the carboxy terminus. Am J Respir Cell Mol Biol 16 3 (1997) 232-241
172. Sheehan J.K., Kirkham S., Howard M., Woodman P., Kutay S., Brazeau C., et al. Identification of molecular intermediates in the assembly pathway of the MUC5AC mucin. J Biol Chem 279 15 (2004) 15698-15705
173. Shibahara H., Tamada S., Goto M., Oda K., Nagino M., Nagasaka T., et al. Pathologic features of mucin-producing bile duct tumors: two histopathologic categories as counterparts of pancreatic intraductal papillary-mucinous neoplasms. Am J Surg Pathol 28 3 (2004) 327-338
174. Shibahara H., Tamada S., Higashi M., Goto M., Batra S.K., Hollingsworth M.A., et al. MUC4 is a novel prognostic factor of intrahepatic cholangiocarcinoma-mass forming type. Hepatology 39 1 (2004) 220-229
175. Shimoda S., Van de Water J., Ansari A., Nakamura M., Ishibashi H., Coppel R.L., et al. Identification and precursor frequency analysis of a common T cell epitope motif in mitochondrial autoantigens in primary biliary cirrhosis. J Clin Invest 102 10 (1998) 1831-1840
176. Shiojiri N. The origin of intrahepatic bile duct cells in the mouse. J Embryol Exp Morphol 79 (1984) 25-39
177. Shiojiri N., and Sugiyama Y. Immunolocalization of extracellular matrix components and integrins during mouse liver development. Hepatology 40 2 (2004) 346-355
178. Shoda J., Oda K., Suzuki H., Sugiyama Y., Ito K., Cohen D.E., et al. Etiologic significance of defects in cholesterol, phospholipid, and bile acid metabolism in the liver of patients with intrahepatic calculi. Hepatology 33 5 (2001) 1194-1205
179. Shoda J., Tanaka N., and Osuga T. Hepatolithiasis - epidemiology and pathogenesis update. Front Biosci 8 (2003) e398-e409
180. Sirica A.E. Cholangiocarcinoma: molecular targeting strategies for chemoprevention and therapy. Hepatology 41 1 (2005) 5-15
181. Sorensen H.T., Friis S., Olsen J.H., Thulstrup A.M., Mellemkjaer L., Linet M., et al. Risk of liver and other types of cancer in patients with cirrhosis: a nationwide cohort study in Denmark. Hepatology 28 4 (1998) 921-925
182. Srivatsa G., Giraud A.S., Ulaganathan M., Yeomans N.D., Dow C., and Nicoll A.J. Biliary epithelial trefoil peptide expression is increased in biliary diseases. Histopathology 40 3 (2002) 261-268
183. Steiner P.E., and Higginson J. Cholangiolocellular carcinoma of the liver. Cancer 12 4 (1959) 753-759
184. Sternberg L.R., Byrd J.C., Yunker C.K., Dudas S., Hoon V.K., and Bresalier R.S. Liver colonization by human colon cancer cells is reduced by antisense inhibition of MUC2 mucin synthesis. Gastroenterology 116 2 (1999) 363-371
185. Summerfields J., Nagafichi Y., and Sherlock S. Hepatobiliary fibropolycystic disease: a clinicl and histological review of 51 patients. J Hepatol 2 (1986) 141-156
186. Takagawa M., Muguruma N., Oguri K., Imoto Y., Okamoto K., Ii K., et al. Prediction of prognosis in gallbladder carcinoma by mucin and p53 immunohistochemistry. Dig Dis Sci 50 8 (2005) 1410-1413
187. Tamada S., Goto M., Nomoto M., Nagata K., Shimizu T., Tanaka S., et al. Expression of MUC1 and MUC2 mucins in extrahepatic bile duct carcinomas: its relationship with tumor progression and prognosis. Pathol Int 52 11 (2002) 713-723
188. Taylor-Papadimitriou J., Peterson J.A., Arklie J., Burchell J., Ceriani R.L., and Bodmer W.F. Monoclonal antibodies to epithelium-specific components of the human milk fat globule membrane: production and reaction with cells in culture. Int J Cancer 28 1 (1981) 17-21
189. Terada T., Nakanuma Y., and Ohta G. Glandular elements around the intrahepatic bile ducts in man: their morphology and distribution in normal livers. Liver 7 (1987) 1-8
190. Terada T., Kida T., Nakanuma Y., Kurumaya H., Doishita K., and Takayanagi N. Intrahepatic cholangiocarcinomas associated with nonbiliary cirrhosis. A clinicopathologic study. J Clin Gastroenterol 18 4 (1994) 335-342
191. Terris B., Blaveri E., Crnogorac-Jurcevic T., Jones M., Missiaglia E., Ruszniewski P., et al. Characterization of gene expression profiles in intraductal papillary-mucinous tumors of the pancreas. Am J Pathol 160 5 (2002) 1745-1754
192. The European Polycystic Kidney Disease Consortium. The polycystic kidney disease 1 gene encodes a 14 kb transcript and lies within a duplicated region on chromosome 16. Cell 77 6 (1994) 881-894
193. Thim L., and May F.E. Structure of mammalian trefoil factors and functional insights. Cell Mol Life Sci 62 24 (2005) 2956-2973
194. Thim L., Madsen F., and Poulsen S.S. Effect of trefoil factors on the viscoelastic properties of mucus gels. Eur J Clin Invest 32 7 (2002) 519-527
195. Thornton D.J., and Sheehan J.K. From mucins to mucus: toward a more coherent understanding of this essential barrier. Proc Am Thorac Soc 1 1 (2004) 54-61
196. Tino M.J., and Wright J.R. Glycoprotein-340 binds surfactant protein-A (SP-A) and stimulates alveolar macrophage migration in an SP-A-independent manner. Am J Respir Cell Mol Biol 20 4 (1999) 759-768
197. Tomasetto C., Rio M.C., Gautier C., Wolf C., Hareuveni M., Chambon P., et al. hSP, the domain-duplicated homolog of pS2 protein, is co-expressed with pS2 in stomach but not in breast carcinoma. EMBO J 9 2 (1990) 407-414
198. Tomasetto C., Masson R., Linares J.L., Wendling C., Lefebvre O., Chenard M.P., et al. pS2/TFF1 interacts directly with the VWFC cysteine-rich domains of mucins. Gastroenterology 118 1 (2000) 70-80
199. Toribara N.W., Roberton A.M., Ho S.B., Kuo W.L., Gum E., Hicks J.W., et al. Human gastric mucin. Identification of a unique species by expression cloning. J Biol Chem 268 8 (1993) 5879-5885
200. Trotman B., Ostrow J., and Soloway R. Pigment vs cholesterol cholelithiasis: composition of stone and bile composition. Am J Dig Dis 19 (1974) 585-590
201. Tsukamoto T., Mizoshita T., Mihara M., Tanaka H., Takenaka Y., Yamamura Y., et al. Sox2 expression in human stomach adenocarcinomas with gastric and gastric-and-intestinal-mixed phenotypes. Histopathology 46 6 (2005) 649-658
202. Tsutsumida H., Swanson B.J., Singh P.K., Caffrey T.C., Kitajima S., Goto M., et al. RNA interference suppression of MUC1 reduces the growth rate and metastatic phenotype of human pancreatic cancer cells. Clin Cancer Res 12 10 (2006) 2976-2987
203. Uchino H., Kataoka H., Itoh H., hamasuna R., and Koono M. Overexpression of intestinal trefoil factor in human colon carcinoma cells reduces cellular growth in vitro and in vivo. Gastroenterol 118 (2000) 60-69
204. van de Wiel-van Kemenade E., Ligtenberg M.J., de Boer A.J., Buijs F., Vos H.L., Melief C.J., et al. Episialin (MUC1) inhibits cytotoxic lymphocyte-target cell interaction. J Immunol 151 2 (1993) 767-776
205. Van Eyken P., Sciot R., Callea F., Van der Steen K., Moerman P., and Desmet V.J. The development of the intrahepatic bile ducts in man: a keratin-immunohistochemical study. Hepatology 8 6 (1988) 1586-1595
206. van Klinken B.J., Dekker J., van Gool S.A., van Marle J., Buller H.A., and Einerhand A.W. MUC5B is the prominent mucin in human gallbladder and is also expressed in a subset of colonic goblet cells. Am J Physiol 274 5, Part 1 (1998) G871-G878
207. Van Seuningen I., Pigny P., Perrais M., Porchet N., and Aubert J.P. Transcriptional regulation of the 11p15 mucin genes. Towards new biological tools in human therapy, in inflammatory diseases and cancer?. Front Biosci 6 (2001) D1216-D1234
208. Vandenhaute B., Buisine M.P., Debailleul V., Clement B., Moniaux N., Dieu M.C., et al. Mucin gene expression in biliary epithelial cells. J Hepatol 27 6 (1997) 1057-1066
209. Vatanasapt V., Martin N., Sriplung H., Chindavijak K., Sontipong S., Sriamporn H., et al. Cancer incidence in Thailand, 1988-1991. Cancer Epidemiol Biomarkers Prev 4 (1995) 475-483
210. Vatanasapt V., Sripa B., Sithithaworn P., and Mariang P. Liver flukes and liver cancer. Cancer Surv 33 (1999) 313-343
211. Velcich A., Yang W., Heyer J., Fragale A., Nicholas C., Viani S., et al. Colorectal cancer in mice genetically deficient in the mucin Muc2. Science 295 5560 (2002) 1726-1729
212. Verdugo P., Aitken M., Langley L., and Villalon M.J. Molecular mechanism of product storage and release in mucin secretion. II. The role of extracellular Ca++. Biorheology 24 6 (1987) 625-633
213. Wahrenbrock M., Borsig L., Le D., Varki N., and Varki A. Selectin-mucin interactions as a probable molecular explanation for the association of Trousseau syndrome with mucinous adenocarcinomas. J Clin Invest 112 6 (2003) 853-862
214. Wang D.Q., Paigen B., and Carey M.C. Phenotypic characterization of Lith genes that determine susceptibility to cholesterol cholelithiasis in inbred mice: physical-chemistry of gallbladder bile. J Lipid Res 38 7 (1997) 1395-1411
215. Wang H.H., Afdhal N.H., Gendler S.J., and Wang D.Q. Evidence that gallbladder epithelial mucin enhances cholesterol cholelithogenesis in MUC1 transgenic mice. Gastroenterology 131 1 (2006) 210-222
216. Wiede A., Jagla W., Welte T., Kohnlein T., Busk H., and Hoffmann W. Localization of TFF3, a new mucus-associated peptide of the human respiratory tract. Am J Respir Crit Care Med 159 4, Part 1 (1999) 1330-1335
217. Williams S.J., McGuckin M.A., Gotley D.C., Eyre H.J., Sutherland G.R., and Antalis T.M. Two novel mucin genes down-regulated in colorectal cancer identified by differential display. Cancer Res 59 16 (1999) 4083-4089
218. Wreschner D.H., McGuckin M.A., Williams S.J., Baruch A., Yoeli M., Ziv R., et al. Generation of ligand-receptor alliances by "SEA" module-mediated cleavage of membrane-associated mucin proteins. Protein Sci 11 3 (2002) 698-706
219. Wu X.S., Akiyama Y., Igari T., Kawamura T., Hiranuma S., Shibata T., et al. Expression of homeodomain protein CDX2 in gallbladder carcinomas. J Cancer Res Clin Oncol 131 5 (2005) 271-278
220. Yamashita K., Yonezawa S., Tanaka S., Shirahama H., Sakoda K., Imai K., et al. Immunohistochemical study of mucin carbohydrates and core proteins in hepatolithiasis and cholangiocarcinoma. Int J Cancer 55 1 (1993) 82-91
221. Yamato T., Kurumaya H., Ohama K., Yamamichi N., Watanabe Y., Harada K., et al. Frequent expression of mucin core protein MUC1 in non-neoplastic gallbladder mucosa from patients with pancreaticobiliary maljunction. Liver 19 4 (1999) 281-287
222. Yamato T., Sasaki M., Watanabe Y., and Nakanuma Y. Expression of MUC1 and MUC2 mucin core proteins and their messenger RNA in gall bladder carcinoma: an immunohistochemical and in situ hybridization study. J Pathol 188 1 (1999) 30-37
223. Yasoshima M., Kono N., Sugawara H., Katayanagi K., Harada K., and Nakanuma Y. Increased expression of interleukin-6 and tumor necrosis factor-alpha in pathologic biliary epithelial cells: in situ and culture study. Lab Invest 78 1 (1998) 89-100
224. Yio X., Diamond M., Zhang J.Y., Weinstein H., Wang L.H., Werther L., et al. Trefoil factor family-1 mutations enhance gastric cancer cell invasion through distinct signaling pathways. Gastroenterology 130 6 (2006) 1696-1706
225. Yovchev M.I., Grozdanov P.N., Joseph B., Gupta S., and Dabeva M.D. Novel hepatic progenitor cell surface markers in the adult rat liver. Hepatology 45 1 (2007) 139-149
226. Zen Y., Harada K., Sasaki M., Tsuneyama K., Katayanagi K., Yamamoto Y., et al. Lipopolysaccharide induces overexpression of MUC2 and MUC5AC in cultured biliary epithelial cells: possible key phenomenon of hepatolithiasis. Am J Pathol 161 4 (2002) 1475-1484
227. Zhou H., Schaefer N., Wolff M., and Fischer H.P. Carcinoma of the ampulla of Vater: comparative histologic/immunohistochemical classification and follow-up. Am J Surg Pathol 28 7 (2004) 875-882